Stryker wins FDA approval for Surpass Streamline brain aneurysm device

Stryker wins FDA approval for Surpass Streamline brain aneurysm device

Source: 
Mass Device
snippet: 

Stryker (NYSE:SYK) said today that it won pre-market approval from the FDA for its Surpass Streamline flow diverter for treating certain types of brain aneurysm.